期刊文献+

二十二碳六烯酸促进无葡萄糖条件下乳腺癌细胞MDA-MB-231死亡 被引量:1

Docosahexaenoic Acid Promoted Death of Breast Cancer MDA-MB-231 Cells under Glucose Deprivation
原文传递
导出
摘要 为了探究二十二碳六烯酸(docosahexaenoic acid,DHA)抗乳腺癌的机制,采用流式细胞术分析细胞死亡率,H2DCFDA探针流式细胞术测定细胞内活性氧(reactive oxygen species,ROS)水平,Western blotting方法检测细胞内剪切型Caspase-3的变化。结果发现在无葡萄糖条件下,DHA以浓度依赖性方式促进乳腺癌细胞MDA-MB-231死亡。在这个过程中,DHA促使细胞内ROS水平明显升高,然而,当DHA和抗氧化剂N-乙酰-半胱氨酸(N-acetyl-L-cystein,NAC)共处理细胞时,细胞死亡率和细胞内ROS水平均明显降低。Western blotting检测结果表明DHA可以引起Caspase-3的切割,同时,这种变化可以被NAC抑制。结果表明在无葡萄糖条件下,DHA可以通过增加细胞内ROS的水平,激活Caspase凋亡通路,进而促进乳腺癌细胞MDA-MB-231死亡。 To study the effects of docosahexaenoic acid (DHA) on breast cancer cells and the underlying mechanisms, celt death was detected by flow cytometry (FCM) with PI fluorescence staining. Intracellular reactive oxygen species (ROS) was measured by FCM using H2DCFDA. The activity of Caspase-3 protein was examined by Western blotting. The results showed that.. DHA could enhance the death of MDA-MB-231 cells after 24 h treatment in a concentration-dependent manner under the condition of glucose starvation. The FCM with the probe of DCF indicated that DHA markedly promoted accumulation of intracellular ROS. However, after treatment with N-acetyI-L-cystein (NAC), the death rate of cells and the ROS level decreased. Western blotting analysis confirmed that co-treatment with NAC could partially attenuate the cleavage of Caspase-3 induced by DHA. The data demonstrated that DHA could enhance the death of glucose-starved MDA-MB-231 cells, which was associated with intracellular accumulation of ROS and activation of Caspase pathway.
出处 《生物物理学报》 CAS CSCD 北大核心 2014年第4期285-290,共6页 Acta Biophysica Sinica
基金 "973"计划项目(2009CB918904) 江苏省异种移植重点实验室项目(BM2012116)~~
关键词 二十二碳六烯酸 MDA-MB-231细胞 活性氧 肿瘤细胞死亡 葡萄糖缺乏 Docosahexaenoic acid MDA-MB-231 cells Reactive oxygen species Tumor cell death Glucose deprivation
  • 相关文献

参考文献16

  • 1Terry PD, Rohan T, Wolk A. Intakes of fish and marine fatty acids and the risks of cancers of the breast and prostate and of other hormonerelated cancers: A review of epidemiologic evidence. Am J Clin Nutr, 2003, 77(3): 532-543.
  • 2Engeset D, Alsaker E, Lund E, Welch A, Khaw KT, ClaveI-Chapelon F, Thiebaut A, Chajes V, Key T J, Allen NE, Amiano P, Dorronsoro M, Tjonneland A, Stripp C, Peeters PH, van Gils CH, Chirlaque MD, Nagel G, Linseisen J, Ocke MC, Bueno-de-Mesquita HB, Sacerdote C, Tumino R, Ardanaz E, Sa nchez M J, Panico S, Palli D, Trichopoulou A, Kalapothaki V, Benetou V, Quiros JR, Agudo A, Overvad K, Bjerregaard L, Wirfalt E, Schulz M, Boeing H, Slimani N, Riboli E. Fish consumption and breast cancer risk. The European prospective investigation into cancer and nutrition (EPIC). Int J Cancer, 2006, 119(1): 175-182.
  • 3Wu M, Harvey KA, Ruzmetov N, Welch ZR, Sech L, Jackson K, StillweU W, Zaloga GP, Siddiqui RA. Omega-3 polyunsaturated fatty acids attenuate breast cancer growth through activation of a neutral sphingomyelinase-mediated pathway. Int J Cancer, 2005, 117(3): 340-348.
  • 4Blanckaert V, Ulmann L, Mimouni V, Antol J, Brancquart L, Chenais B. Docosahexaenoic acid intake decreases proliferation, increases apoptosis and decreases the invasive potential of the human breast carcinoma cell line MDAMB-231. Int J Oncol, 2010, 36(3): 737-742.
  • 5Bernard-Gallon D J, Vissac-Sabatier C, Antoine-Vincent D, Rio PG, Maurizis JC, Fustier P, Bignon YJ. Differential effects of n-3 and n-6polyunsaturated fatty acids on BRCA-1 and BRCA-2 gene expression in breast cell lines. Br J Nutr, 2002, 87(4): 281-289.
  • 6Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A. Dietary long-chain n-3 fatty acids for the prevention of cancer: A review of potential mechanisms. Am J Clin Nutr, 2004, 79(6): 935-945.
  • 7Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell, 2011, 144(5): 646-674.
  • 8Chung AS, Lee J, Ferrara N. Targeting the tumor vasculature: insights from physiological angiogenesis. Nat Rev Cancer, 2010, 10(7): 505-514.
  • 9Lu J, Kunimoto S, Yamazaki Y, Kaminishi M, Esumi H.Kigamicin D, a novel anticancer agent based on a new anti-austerity strategy targeting cancer cells' tolerance to nutrient starvation. Cancer Sci, 2004, 95(6): 547-552.
  • 10Park HR, Ryoo I J, Choo S J, Hwang JH, Kim JY, Cha MR, Shin-Ya K, Yoo ID. Glucose-deprived HT-29 human colon carcinoma cells are sensitive to verrucosidin as a GRP78 down-regulator. Toxicology, 2007, 2(29): 253-261.

同被引文献9

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部